Mirus completes 409A valuation for Ahura Corporation

Ahura makes portable optical analyzers that are rugged, handheld Raman spectrometers designed for rapid and precise chemical identification, authentication, and screening directly at the point of need. Whether at a pharmaceutical manufacturing facility or at a potential security incident, our handheld instruments provide the chemical analysis information our customers need — where and when they need it. Our products are in active use worldwide in the safety and security, pharmaceutical and consumer health, aviation security, and industrial processing markets. In 2009, Mirus completed a 409A valuation for the Company, valuing its common stock for purposes of an employee ISO plan. In February 2010, Ahura was purchased by Thermo Scientific.

About Mirus Capital Advisors

Mirus Capital Advisors provides investment banking solutions to corporate clients in technology, business services, manufacturing, consumer products, health care, and the resort & hospitality industry. Since 1987, Mirus has provided corporate finance advisory services on engagements including mergers, acquisitions, divestitures, recapitalizations, and valuations. For additional information, visit www.merger.com.